| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |